Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Virax Biolabs Group (NASDAQ:VRAX) through any online brokerage.
There are no as such competitors for Virax Biolabs Group.
Virax Biolabs Group has a consensus price target of $1.00.
The stock price for Virax Biolabs Group (NASDAQ: VRAX) is $0.165 last updated June 18, 2026 at 7:58 PM EDT.
There are no upcoming dividends for Virax Biolabs Group.
Virax Biolabs Group does not have any upcoming earnings scheduled.
There is no upcoming split for Virax Biolabs Group.
Virax Biolabs Group is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.